Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
10,563
+3,221
+44% +$584K 0.27% 76
2026
Q1
$1.08M Buy
7,342
+4,375
+147% +$711K 0.27% 74
2025
Q4
$578K Sell
2,967
-8,317
-74% -$1.98M 0.13% 137
2025
Q3
$3.17M Buy
11,284
+5,926
+111% +$1.51M 0.6% 27
2025
Q2
$1.17M Buy
+5,358
New +$865K 0.2% 114

Other funds holding ORCL

111 Capital's ORCL Position: Q2 2026 in Review

111 Capital increased its Oracle (ORCL) stake by 44% in Q2 2026, buying an estimated $584K and bringing the position to 10,563 shares worth $1.55M. The position accounts for 0.27% of the portfolio, ranked #76.

111 Capital first reported a position in ORCL in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.17M in Q3 2025. 3,531 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • 111 Capital held 10,563 shares of Oracle worth $1.55M as of Q2 2026.
  • 111 Capital bought 3,221 Oracle shares in Q2 2026, an estimated $584K.
  • Oracle made up 0.27% of 111 Capital's portfolio in Q2 2026, its #76 holding.
  • 111 Capital first reported a position in Oracle in Q2 2025 and has held it in 5 quarters since.
  • 111 Capital's Oracle position peaked at $3.17M in Q3 2025.
  • 3,531 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.